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Abstract. 
 
The spindle checkpoint prevents errors in
chromosome segregation by inhibiting anaphase onset
until all chromosomes have aligned at the spindle equa-
tor through attachment of their sister kinetochores to
microtubules from opposite spindle poles. A key check-
point component is the mitotic arrest–deﬁcient protein
2 (Mad2), which localizes to unattached kinetochores
and inhibits activation of the anaphase-promoting com-
plex (APC) through an interaction with Cdc20. Recent
studies have suggested a catalytic model for kineto-
chore function where unattached kinetochores provide
sites for assembling and releasing Mad2–Cdc20 com-
plexes, which sequester Cdc20 and prevent it from acti-
vating the APC. To test this model, we examined Mad2
dynamics in living PtK1 cells that were either injected
with ﬂuorescently labeled Alexa 488-XMad2 or trans-
fected with GFP-hMAD2. Real-time, digital imaging
revealed ﬂuorescent Mad2 localized to unattached ki-
netochores, spindle poles, and spindle ﬁbers depending
on the stage of mitosis. FRAP measurements showed
 
that Mad2 is a transient component of unattached kinet-
 
ochores, as predicted by the catalytic model, with a 
 
t
 
1/2
 
of 
 
z
 
24–28 s. Cells entered anaphase 
 
z
 
10 min after
Mad2 was no longer detectable on the kinetochores of
the last chromosome to congress to the metaphase
plate. Several observations indicate that Mad2 binding
sites are translocated from kinetochores to spindle
poles along microtubules. First, Mad2 that bound to
sites on a kinetochore was dynamically stretched in
both directions upon microtubule interactions, and
Mad2 particles moved from kinetochores toward the
poles. Second, spindle ﬁber and pole ﬂuorescence dis-
appeared upon Mad2 disappearance at the kinet-
ochores. Third, ATP depletion resulted in microtu-
bule-dependent depletion of Mad2 ﬂuorescence at
kinetochores and increased ﬂuorescence at spindle
poles. Finally, in normal cells, the half-life of Mad2 turn-
over at poles, 23 s, was similar to kinetochores. Thus, ki-
netochore-derived sites along spindle ﬁbers and at spin-
dle poles may also catalyze Mad2 inhibitory complex
formation.
Key words: cell cycle • mitosis • spindle checkpoint •
chromosome • microtubule
 
Introduction
 
The gain or loss of a single chromosome kills cells, contrib-
utes to tumor progression, and leads to birth defects.
Therefore, to prevent aneuploidy, cells have evolved a sur-
veillance mechanism, known as the spindle checkpoint,
which regulates anaphase onset and prevents entry into
anaphase until all chromosomes have become properly at-
tached and aligned on the spindle. Continuing chromo-
some loss and gain is seen in most colorectal cancers (Len-
gauer et al., 1997) and probably many other types of
cancer, and can result from mutational inactivation of a
spindle checkpoint protein (Cahill et al., 1998).
Genetic screens in budding yeast have identified several
components of the spindle checkpoint. These include the
kinetochore proteins Mad1, 2, and 3 (Li and Murray,
1991), budding uninhibited by benzimidazole (Bub)
 
1
 
 1, 2,
and 3 (Hoyt et al., 1991), and Mps1 (Hardwick et al., 1996;
Weiss and Winey, 1996), which are required to delay cell
cycle progression in response to spindle damage or to de-
fects in kinetochore and centromere structure. Homo-
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Abbreviations used in this paper: 
 
APC, anaphase-promoting complex;
Bub, budding uninhibited by benzimidazole; GFP, green fluorescent pro-
tein; hMad2, human Mad2; Mad2, mitotic arrest–deficient protein 2;
XMad2, 
 
Xenopus
 
 Mad2. 
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logues of the mitotic arrest–deficient protein 2 (Mad2) and
other checkpoint components have been identified re-
cently in fission yeast and higher eukaryotes and shown
to be highly conserved. For example, 
 
Xenopus
 
 Mad2
(XMad2) shares a 41 and 81% identity with the yeast
(scMad2) and human (hMad2) homologues, respectively
(Chen et al., 1996; Li and Benezra, 1996). Further studies
have shown Mad2 to have important roles in the spindle
checkpoint in these organisms (for review see Hardwick,
1998). For instance, in yeast and mice, the absence of
Mad2 results in increased frequency of spontaneous chro-
mosome loss (Li and Murray, 1991; Amon, 1998; Hard-
wick, 1998; Dobles et al., 2000), and in mammalian cells
and cytoplasmic extracts, electroporation or microinjec-
tion of anti-Mad2 antibodies allows cells that have not
aligned all of their chromosomes on the spindle to enter
anaphase (Chen et al., 1996, 1998; Li and Benezra, 1996;
Gorbsky et al., 1998; Waters et al., 1998; Canman et al.,
2000). Furthermore, Mad2-null mouse cells do not arrest
in response to spindle damage, show widespread chromo-
some missegregation, and undergo apoptosis during initia-
tion of gastrulation (Dobles et al., 2000). Mad2 and several
other checkpoint components have been shown to immu-
nolocalize to kinetochores that lack bound microtubules
or have only a small fraction of their microtubule binding
sites occupied, and to disappear from kinetochores as they
become fully occupied with kinetochore microtubules dur-
ing chromosome alignment at the spindle equator in
prometaphase (for reviews see Hardwick, 1998; Rieder
and Salmon, 1998; Amon, 1999). Mad1 has been shown to
be required for Mad2 localization to unattached kineto-
chores (Chen et al., 1998).
A variety of evidence suggests the defects that activate
the spindle checkpoint occur at kinetochores (Rieder and
Salmon, 1998). In 1995, Rieder et al. demonstrated that
destruction of the last unattached kinetochore by laser ab-
lation causes cells to enter anaphase. Furthermore, using
micromanipulation of meiotic insect spermatocytes to
move a chromosome far enough away from the metaphase
plate to interfere with microtubule attachment inhibited
anaphase onset (Li and Nicklas, 1995; Zhang and Nicklas,
1996). How does the cell know that a single kinetochore is
improperly attached to the spindle?
Recent studies have identified a link between Mad2 and
the cell cycle proteins that regulate anaphase onset (for re-
view see Elledge, 1998). Initial studies in fission yeast
identified a genetic interaction between Mad2 and the
anaphase-promoting complex (APC; He et al., 1997). APC
is involved in the ubiquitination and degradation of cyclin
B1 (Holloway et al., 1993) and anaphase inhibitory pro-
teins, such as Pds1/Cut2 (King et al., 1996), and its activa-
tion during mitosis requires an interaction with Cdc20
(Visitin et al., 1997; Fang et al., 1998; Hwang et al., 1998).
Cdc20 has been shown to localize to kinetochores from
late prophase to telophase, and partially to spindle micro-
tubules and spindle poles (Kallio et al., 1998). Genetic
analysis in fission and budding yeasts and biochemical ex-
periments in frog egg extracts have shown that Cdc20 is
the target that the spindle checkpoint inhibits; mutations
in Cdc20 that block the binding of Mad2 destroy the
checkpoint, and a tetrameric form of Mad2 binds Cdc20
and interferes with its ability to activate the APC in in
vitro assays (Fang et al., 1998; Hwang et al., 1998; Kim et
al., 1998). Therefore, the current model proposes that un-
attached kinetochores serve as catalytic sites for assem-
bling Mad2–Cdc20 complexes, which sequester Cdc20
molecules that could otherwise bind to and activate the
APC. It has been suggested that production of the inhibi-
tory complex is halted when kinetochores on the last chro-
mosome become attached to the spindle, allowing Cdc20
to dissociate from Mad2 and activate the APC (Kallio et
al., 1998; Chen et al., 1998).
Immunofluorescence and biochemical studies have
greatly enhanced our current understanding of the spindle
checkpoint by localizing various checkpoint components
to unattached kinetochores, and identifying the formation
of checkpoint protein complexes (Chen et al., 1996, 1999;
Taylor and McKeon, 1997; Fang et al., 1998; Gorbsky et
al., 1998; Hwang et al., 1998; Kim et al., 1998; Waters et al.,
1998). To examine Mad2 localization and dynamics in vivo
and to test the transitory nature of Mad2 at unattached ki-
netochores, we microinjected living PtK1 cells with fluo-
rescently labeled XMad2 or transfected the cells with
green fluorescent protein (GFP)–hMAD2. Overall, by live
cell analysis we found that fluorescent Mad2 is predomi-
nantly diffuse in the cytoplasm of PtK1 cells, localizes to
unattached kinetochores during prophase, and depletes
from kinetochores as they attach to the spindle. Further-
more, we observed cells entered anaphase 
 
z
 
10 min after
depletion of Mad2 on the kinetochore of the last congress-
ing chromosome. Using FRAP techniques, we demon-
strated that Mad2 is a transient component of both kineto-
chores and spindle poles with an average 
 
t
 
1/2 
 
of 
 
z
 
24–28 s.
In addition, we found that treatment of cells with meta-
bolic inhibitors resulted in a decreased turnover of Mad2
protein, whereas nocodazole treatment had little effect.
Finally, we observed microtubule-dependent transport of
Mad2 particles between kinetochores and spindle poles
and found a subsequent loss of Mad2 protein at the spin-
dle poles when it disappeared from proximal kinetochores.
These observations indicate that a portion of Mad2 bind-
ing sites at kinetochores is translocated to spindle poles
along the spindle fibers.
 
Materials and Methods
 
Cell Culture and Drug Treatment
 
PtK1 cells (American Type Culture Collection) were grown on coverslips
and maintained in Ham’s F12 medium, pH 7.2 (Sigma Chemical Co.) sup-
plemented with 10% FBS, 100 U/ml penicillin, 0.1 mg/ml streptomycin,
and 0.25 
 
m
 
g/ml amphotericin B in a 37
 
8
 
C, 5% CO
 
2
 
 incubator. Before mi-
croinjection or filming, cells were incubated in dye-free L-15 medium, pH
7.2 (Sigma Chemical Co.), supplemented with 7 mM Hepes, 10% FBS,
and antibiotics/antimycotic solution as described above. For experiments
in which nocodazole was used, 10 mg/ml nocodazole in DMSO stock
(Sigma Chemical Co.) was diluted into L-15 medium for a final concentra-
tion of 20 
 
m
 
g/ml.
 
Mad2 Protein Expression, Purification, and
Fluorescent Labeling
 
Full-length XMAD2 tagged with six histidines at the NH
 
2
 
 terminus was
expressed in 
 
Escherichia coli
 
 using Qiaexpress vector pQE10 (QIAGEN)
as previously described by Chen et al. (1996). Recombinant XMad2 pro-
tein was purified under nondenaturing conditions according to the manu-
facturer’s instructions. Purified protein was dialyzed against PBS (140 mM 
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NaCl, 2.5 mM KCl, 10 mM Na
 
2
 
HPO
 
4
 
, and 1.5 mM KH
 
2
 
PO
 
4
 
, pH 7.8) over-
night and spun at 30,000 rpm, 4
 
8
 
C, for 20 min in a Beckman tabletop ultra-
centrifuge to remove any protein precipitate. Purified protein was run on
an SDS 12.5% polyacrylamide gel and visualized by silver stain.
The pH of 1 mg XMad2 protein was adjusted to pH 8.2–8.6 with 0.1 M
NaHCO
 
3
 
, and added to 0.1 mg of Alexa 488 succinimidyl ester reactive
dye (Molecular Probes, Inc.). After gentle stirring for 30 min at 25
 
8
 
C, the
reaction was stopped for another 30-min period by the addition of 0.05 M
hydroxylamine, pH 8.5. Fluorescent XMad2 protein was separated from
unincorporated dye by centrifugation through a Bio-Spin P6 column (Bio-
Rad Laboratories) preequilibrated with injection buffer (IB: 10 mM
Na
 
2
 
HPO
 
4
 
, pH 7.4, 100 mM KCl, and 1 mM MgCl
 
2
 
). The eluted fluorescent
XMad2 protein was collected and centrifuged at 30,000 rpm, 4
 
8
 
C, for 20
min to remove protein aggregates, and spectroscopy readings were taken
at A
 
280
 
 nm and A
 
490
 
 nm to determine the protein concentration and label-
ing efficiency. The final dye-to-protein ratio was 
 
z
 
3:1. The Alexa 488-
XMad2 (6–7-
 
m
 
M stock) was distributed in 20-
 
m
 
l aliquots, frozen in liquid
nitrogen, and stored at 
 
2
 
80
 
8
 
C.
XMad2 protein in PBS buffer was subjected to sedimentation velocity
ultracentrifugation at 12,000 rpm at 20
 
8
 
C for 3–4 h in an AN60-Ti rotor in
a Beckman Optima XLA analytical ultracentrifuge equipped with absorp-
tion optics. A two-sector cell was used; one cell was loaded with 450 
 
m
 
l of
buffer, and the other with 350 
 
m
 
l of XMad2 protein. Absorption scans
were taken every 2 min at 290 nm and the average molecular mass for
the whole distribution was determined using XLA Origin software
(Beckman).
 
Microinjection
 
Before microinjection, coverslips were mounted in modified Rose cham-
bers (Rieder and Hard, 1990) lacking the top coverslip, and the chambers
were filled with Hepes-buffered, L-15 medium to sustain the cells (de-
scribed above). A circle was inscribed on the bottom coverslip using a dia-
mond-tip scribing objective (Carl Zeiss, Inc.) and was used as a reference
for relocating injected cells. Alexa 488-XMad2 protein was diluted into IB
and injected into interphase and mitotic cells at 1.5 
 
m
 
M (needle concentra-
tion) on a Zeiss IM microscope equipped with phase optics and a 40
 
3
 
,
0.75 NA objective. The microinjection system is essentially as described in
Waters et al. (1996). The stage temperature was maintained at 32–34
 
8
 
C us-
ing a Sage air curtain incubator. Immediately after injection, the chamber
was sealed by adding a top coverslip and filled using a syringe and needle
with fresh, dye-free, high glucose (4.5 g/l) L-15 medium supplemented
with 0.3 U/ml of the oxygen-scavenging enzyme, Oxyrase (Oxyrase, Inc.).
 
GFP-hMad2 Transfection and Expression
 
The full-length coding sequence for hMAD2 was subcloned between the
5
 
9
 
 BamHI and XbaI 3
 
9
 
 sites of the pCS2-GFP mammalian expression vec-
tor (a gift from Dr. Robert Davis, Harvard Medical School, Cambridge,
MA) so that the GFP fusion gene was at the NH
 
2
 
-terminal end of
hMAD2. PtK1 cells were subcultured on 22-mm coverslips in 10-mm plas-
tic Petri dishes and were transfected using Effectene (QIAGEN). Addi-
tional control cultures were transfected with the plasmid pCS2-GFP,
which codes for GFP without hMAD2. After a 6–12-h incubation, cells
were rinsed with PBS to remove the transfection mixture, incubated in
Ham’s F12 medium (as described above), and viewed 48 h later using fluo-
rescence and phase-contrast microscopy.
 
Immunofluorescence
 
For Mad2 immunofluorescence, cells were rinsed quickly with 60 mM
Pipes, 25 mM Hepes, pH 6.9, 10 mM EGTA, 4 mM MgSO
 
4
 
 (PHEM) and
lysed with 0.5% Triton X-100/PHEM for 5 min at 37
 
8
 
C. After a quick
rinse in PHEM, cells were fixed for 20 min in freshly prepared 4.0% form-
aldehyde/PHEM at 37
 
8
 
C. The following steps were all carried out at room
temperature (25
 
8
 
C). Cells were rinsed three times for 5 min with PBS con-
taining 0.05% Tween-20 (PBST) and subsequently blocked with 10%
boiled normal donkey serum/PHEM (Jackson ImmunoResearch Labora-
tories) for 60 min in a humid chamber to prevent nonspecific antibody
binding. Cells were incubated for 45 min in primary antibodies diluted
1:100 into 5% donkey serum. Affinity-purified rabbit anti–XMad2 anti-
bodies were isolated as described previously (Waters et al., 1998). After
four 5-min rinses in PBST, cells were incubated for 45 min in secondary
donkey anti–rabbit antibodies conjugated to rhodamine red-X and diluted
1:100 (Jackson ImmunoResearch Laboratories).
 
For fixation studies after laser photobleaching, cells were immediately
rinsed in PHEM, and fixed within 10–15 s of photobleaching in freshly
prepared 1% paraformaldehyde/PHEM for 45 s at 37
 
8
 
C. Cells were lysed
with 0.5% Triton X-100/PHEM for 5 min at 37
 
8
 
C and fixed for an addi-
tional 20 min in 4.0% formaldehyde/PHEM at 37
 
8
 
C. Cells were further
processed for anti-Mad2 immunofluorescence essentially as described
above.
 
Microscopy and Laser Photobleaching
 
For fluorescence and phase microscopy studies, cells were placed in modi-
fied Rose chambers containing dye-free, high glucose (4.5 g/l), L-15 me-
dium supplemented with Oxyrase (as described above) and imaged on
a Nikon TE300 inverted microscope equipped with a sensitive, Orca
1–cooled CCD camera (Hamamatsu Photonics). Images were obtained
using a 100
 
3
 
 1.4 NA Plan Apo phase 3 objective, a 100-W mercury arc
(attenuated to 
 
z
 
10%) fluorescent light source, and a Chroma Hy-Q FITC
filter set. Photobleaching experiments were performed essentially as de-
scribed by Maddox et al. (2000). In brief, a 488-nm line from an argon la-
ser (Spectra-Physics) was selected through a band-pass filter and shut-
tered to control exposure. The laser was passed through a beam expander
and focused as a spot conjugate with the field diaphragm to a diameter at
half-maximal intensity of 0.8 
 
m
 
m at the specimen plane (Maddox et al.,
2000). A typical experiment consisted of imaging fluorescently labeled
Mad2 kinetochores before opening the laser shutter for 25 ms, and record-
ing fluorescence recovery by time-lapse microscopy. The microscope was
controlled by MetaMorph imaging software (Universal Imaging Corp.),
and the images were collected at various time intervals depending on the
experiment, ranging from 1 frame every 2 s to 1 frame every 60 s, with expo-
sure times of 250 ms. Either single focal planes or a through-focus z-series
stack consisting of three frames at 0.5-
 
m
 
m intervals were acquired at each time
point, depending on experimental conditions. For temporal studies of
anaphase onset, a through-focal series consisting of 0.3–0.4-
 
m
 
m steps was taken
through the cell after the last chromosome congressed to the metaphase plate
to ensure depletion of fluorescent Mad2 from all kinetochores.
 
Metabolic Inhibitor Treatment
 
For studies of Mad2 turnover in ATP-reduced cells, cells were injected
with Alexa 488-XMad2, rinsed twice in saline G (140 mM NaCl, 5 mM
KCl, 0.6 mM MgSO
 
4
 
·7H
 
2
 
O, 0.1 mM CaCl2·2H
 
2
 
O, 1 mM Na
 
2
 
HPO
 
4
 
·7H
 
2
 
O,
1 mM KH
 
2
 
PO
 
4
 
, pH 7.3 supplemented with 4.5 g/L glucose) to remove cul-
ture medium, and were assembled in a sealed Rose chamber. The cham-
ber was perfused with saline supplemented with 5 mM sodium azide
(Sigma Chemical Co.), 1 mM 2-deoxyglucose (Sigma Chemical Co.), and
0.3 U/ml Oxyrase for 5 min. Injected cells were imaged before and after
photobleaching of single kinetochores. Occasionally, cells were rinsed free
of inhibitors, incubated with saline G plus Oxyrase, and used for further
photobleaching and image analysis. Untreated control cells were imaged
in saline G supplemented with Oxyrase.
For studies of Mad2 localization in ATP-reduced cells, PtK1 cells were
microinjected with Alexa 488-XMad2 and assembled into Rose chambers
as described above. Cells were placed in saline G and imaged for fluores-
cent XMad2, incubated with saline supplemented with 5 mM sodium
azide, 1 mM 2-deoxyglucose, and 0.3 U/ml oxyrase for 30 min at 37
 
8
 
C, and
then reimaged. After a 5–10-min washout of inhibitors with saline G, cells
were imaged again for Mad2 fluorescence. For nocodazole studies, cells
were incubated in 20 
 
mM
 
 nocodazole for 20 min at 37
 
8
 
C before incubation
with the ATP inhibitors. Note, 20 
 
m
 
M nocodazole was present throughout
the entire experiment and cells were always maintained at 37
 
8
 
C.
 
Statistical Analysis of FRAP Data
 
MetaMorph software was used to measure integrated fluorescence inten-
sities of kinetochores and spindle poles. In brief, a small circle slightly
larger than the kinetochore was placed over the entire area of a kineto-
chore (or spindle pole) and the area (
 
A
 
s
 
) and integrated fluorescence in-
tensity (
 
F
 
S
 
) for each time point were logged into an Excel spreadsheet. A
circle slightly larger than the smaller circle was placed over the smaller cir-
cle and used to measure kinetochore (or spindle pole) fluorescence plus
cytoplasmic background fluorescence. Measurements of the area (
 
A
 
L
 
) and
integrated fluorescence intensity (
 
F
 
L
 
) of the large circle per time point
were recorded into the spreadsheet, and the following formula was used
to subtract background fluorescence (
 
F
 
BG
 
) and to obtain integrated fluo-
rescence intensity readings minus background: 
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(1)
Graphs of integrated fluorescence intensity minus background versus time
were plotted in Excel. Mad2 half-life (turnover rate) was calculated essen-
tially as described by Maddox et al. (2000). In brief, the first-order rate
constant 
 
k
 
 was determined as previously described (Salmon and Wads-
worth, 1986). The exponential function:
(2)
describes fluorescence recovery of the kinetochore (or spindle pole) after
laser illumination. 
 
F
 
inf
 
 is the intensity of the photobleached region af-
ter maximal recovery; 
 
F(0)
 
 is the intensity of the same region at 
 
t
 
 5 
 
0
(first time point after laser irradiation). The first-order rate constant 
 
k
 
was derived from the slope of a best-fit line through graphs of
versus time for photobleached regions. The half-life of flu-
orescence recovery was calculated by 
 
t
 
1/2
 
 
 
5
 
 ln2/
 
k
 
 (equation 2). The per-
cent fluorescence recovery (%R) was calculated from 
 
F
 
inf
 
, 
 
F(0)
 
 and the
prebleached fluorescence: 100%  , where 
 
F
 
2
 
 is
the prebleach fluorescence measurement. The 
 
t
 
 test and analysis of vari-
ance (ANOVA) were performed using Microsoft Excel.
 
Quantitation of Injected Mad2 Protein in Cells and at 
Unattached Kinetochores
 
Pulled glass microneedle tips were filled with 6.2 
 
m
 
M of Alexa 488-XMad2
in 1 mg/ml BSA and placed on the stage of an inverted microscope (model
TE300; Nikon). BSA was used to block absorption of fluorescent XMad2
to needle surfaces. The tip of the needle was suspended in immersion oil
above the 100
 
3
 
 oil objective and brought into focus. Fluorescent XMad2
images were taken using the same settings described above for the in-
jected cells. Integrated Mad2 fluorescence intensities were measured
within a 4
 
3
 
8–
 
m
 
m box along regions in the tip 
 
z
 
4–5 
 
m
 
m in diameter for
several needle preparations. After background subtraction, the net inte-
grated fluorescence intensity was used to calculate the fluorescence per
micromolar per microliter XMad2 (
 
F
 
N
 
). This number was used to estimate
the concentration and number of molecules of injected XMad2 in mitotic
cells in the following way. First, we calculated the average volume of a mi-
totic PtK1 cell by measuring the diameter of trypsinized cells; the mean di-
ameter (
 
d
 
) was 22 
 
6
 
 2.5 
 
m
 
m, which yielded an average cell volume
(
 
V
 
) 
 
5
 
 4/3
 
p
 
(
 
d
 
/2)
 
3
 
 
 
5
 
 6
 
pL
 
. To obtain estimates of the concentration and
the number of injected XMad2 molecules in the cell, we integrated the
Mad2 fluorescence throughout the cell boundary (
 
F
 
T
 
) in late prophase or
early prometaphase when the cell was extended or flat. The concentration
of injected XMad2 
 
5
 
 
 
F
 
T
 
/(
 
F
 
N
 
 
 
3
 
 
 
V
 
). The total injected XMad2 per cell 
 
5
 
the concentration of injected Mad2 
 
3
 
 
 
V
 
 
 
3
 
 
 
N
 
AV
 
, where 
 
N
 
A
 
V
 
 is Avogadro’s
number (6.023 
 
3
 
 10
 
23
 
 molecules/mole).
 
Online Supplemental Material
 
Quicktime movies of the time-lapse fluorescent and phase Mad2 images
accompanying Figs. 2 (Videos 1 and 2), 5 A (Video 3), 8 (Video 4, an addi-
tional example) and 9 (Video 5) are available at http://www.jcb.org/cgi/
content/full/150/6/1233/DC1.
 
Results
 
Fluorescent Mad2 Protein Localizes to Unattached 
Kinetochores and Spindle Poles in Living PtK1 Cells
 
Interphase and mitotic PtK1 cells were injected with fluo-
rescent XMad2 protein, and Mad2 localization and mitotic
progression were observed using digital imaging fluores-
cence and phase-contrast microscopy. PtK1 cells were cho-
sen as a model system because they are flat, typically
contain 11 large chromosomes, and have been used exten-
sively in studies of the spindle checkpoint (Rieder et al.,
1994, 1995; Gorbsky et al., 1998; Waters et al., 1998, 1999).
After microinjection into the cytoplasm, we found that flu-
orescent XMad2 was diffuse throughout the cytoplasm but
concentrated in the nucleus of interphase (data not
shown) and prophase cells (Fig. 1 A). Consistent with pre-
FS FBG – FS
FL FS – () AS ´
AL AS – ()
----------------------------------- . – =
Finf Ft () – Finf F 0 () – [] e kt – =
[In Finf Ft () – []
Finf F 0 () – [] F2 F 0 () – [] ¤
vious anti-Mad2 immunofluorescence studies in PtK1 cells
and other tissue culture lines (Chen et al., 1996; Waters et
al., 1998; Gorbsky et al., 1998), fluorescent XMad2 local-
ized strongly to kinetochores in late prophase (Fig. 1 A)
and early prometaphase (Fig. 1 B) cells and remained lo-
calized to kinetochores until their chromosomes achieved
bipolar attachment to the spindle during late prometa-
phase and early metaphase (Fig. 1 C and Fig. 2 D). In ad-
dition, fluorescent XMad2 protein localized to the spin-
dle poles during prometaphase and early metaphase (Fig.
1 C, arrowheads), and was frequently observed along spin-
dle microtubules (Fig. 1 B; see Fig. 8). In contrast to previ-
ous fixed cell studies (Chen et al., 1996; Li and Benezra,
1996; Gorbsky et al., 1998; Waters et al., 1998), fluorescent
XMad2 was not enhanced above background at either the
nuclear envelope or prophase centrosomes in living PtK1
cells. Fluorescent XMad2 protein was not evident on ki-
netochores, spindle microtubules, or at the spindle poles
during late metaphase, anaphase, and telophase (Fig. 1 D;
also see Fig. 2, E and F).
Destruction of the spindle by the microtubule-depoly-
merizing agent nocodazole stimulates the spindle check-
point and inhibits cell cycle progression. Chen et al. (1996)
and Waters et al. (1998) showed immunolocalization of
XMad2 to kinetochores in tissue culture cells after no-
codazole treatment. Therefore, we examined the ability of
our fluorescent XMad2 protein to localize to kinetochores
upon nocodazole-induced depolymerization of spindle mi-
crotubules in living PtK1 cells. Cells were incubated in 20
mM nocodazole for 20 min and injected with Alexa 488-
XMad2. Consistent with previous immunofluorescence
studies (Waters et al., 1998), we found that XMad2 local-
ized to kinetochores but not to spindle poles in nocoda-
zole-treated PtK1 cells (data not shown). This observation
was independent of the order in which cells were injected
with fluorescent protein or treated with nocodazole, and
suggests Alexa 488-XMad2 protein can localize to kineto-
chores in the absence of microtubules and upon nocoda-
zole-induced reactivation of the spindle checkpoint. We
also examined the localization patterns of Alexa 488-
XMad2 protein in other cell lines (e.g., LLC-PK, HeLa,
and newt lung epithelia) and found qualitatively similar lo-
calization patterns to those described above (data not
shown). These cells, however, were not used for further
experimentation since they are either smaller, rounder, or
contain more chromosomes than PtK1 cells, making it
more difficult to image fluorescent Mad2 localization dy-
namics in vivo.
To quantitatively estimate the amount of injected
XMad2 protein present in the cell and at unattached ki-
netochores, fluorescent XMad2 images were taken of mi-
croneedle tips filled with known concentrations of Alexa
488-XMad2 protein. XMad2 fluorescence intensities were
measured within a known area of the glass microneedle
and compared with measurements taken within an in-
jected cell (described in Materials and Methods). For in-
jected prometaphase cells containing z150 nM Alexa 488-
XMad2 protein, the amount of fluorescent protein at an
unattached kinetochore was z0.15% of the total cellular
fluorescent XMad2 protein, based on the ratio of inte-
grated fluorescence at kinetochores to the total fluores-
cence in the cell (Fig. 1 B, large arrowhead). The totalHowell et al. Mad2 and Kinetochore Dynamics In Vivo 1237
number of fluorescent XMad2 molecules in the cell was
z540,000 for an average cell volume of 6 pl (see Materials
and Methods). Thus, the number of fluorescent XMad2
molecules bound to an unattached kinetochore at 0.15%
of the total is z810. We don’t know the concentration of
endogenous Mad2 in PtK1 cells, but believe it is likely
near the 100 nM found in HeLa cells (Fang, G., unpub-
lished observations). At 100 nM of endogenous Mad2 plus
150 nM of injected Alexa 488-Mad2 and a 6-pl cell volume,
we estimate the total number of Mad2 molecules at a sin-
gle unattached kinetochore to be z1,300. At intracellular
concentrations of injected Alexa 488-Mad2 above z1,500
nM, the amount of Alexa 488-Mad2 at kinetochores ap-
peared to saturate at z1,500–2,000 molecules (data not
shown).
Mitotic Progression Is Unaltered by the Microinjection 
of Fluorescent XMad2
To assess if the injection procedure or the presence of a
low concentration of Alexa 488-XMad2 (z150 nM final)
affected cell cycle progression in PtK1 cells, we microin-
jected early mitotic cells with fluorescent XMad2 protein
and followed cell progression through mitosis using time-
lapse fluorescence and phase-contrast microscopy. Previ-
ous studies showed that anaphase onset occurs in PtK1
cells z23 min after the last monooriented chromosome bi-
orients and begins congression to the metaphase plate
(Rieder et al., 1994). In addition, cytokinesis is completed
z30 min after anaphase onset (Canman et al., 2000). We
found injected cells progressed normally through mito-
sis and showed no abnormal delays in the metaphase–
anaphase transition (Fig. 2 and Videos 1 and 2 [available
at http://www.jcb.org/cgi/content/full/150/6/1233/DC1]). The
completion of cytokinesis and entry into interphase also
appeared normal in injected cells compared with nonin-
jected cells and previous studies (data not shown; Rieder
et al., 1994; Canman et al., 2000). Cells injected with simi-
lar amounts of unlabeled recombinant XMad2 protein
also showed a normal mitotic progression (data not
shown). Collectively, these studies suggest neither the in-
jection procedure nor the presence of low concentrations
of unlabeled or fluorescent XMad2 protein alters mitotic
progression.
We believe our fluorescent XMad2 probe is functionally
active based on the localization patterns described above
and the additional activity assays described below. For ex-
ample, analytical ultracentrifugation revealed that our pu-
rified recombinant XMad2 protein has an average molecu-
lar mass of 107.5 kD (Fig. 3 A), which is similar to the
molecular mass of the Mad2 complex shown by Fang et al.
(1998) to inhibit Cdc20 activation of the APC in in vitro
assays. Second, we found microinjection of excess unla-
beled or Alexa 488–labeled XMad2 protein (.750 nM fi-
nal) into PtK1 cells causes a mitotic block (data not
shown), which is consistent with similar injection experi-
ments in Xenopus (Chen et al., 1998; Fang et al., 1998) and
overexpression studies in yeast (He et al., 1997). Addition-
ally, previous studies have shown microinjection of cells
with anti-Mad2 antibodies induces premature anaphase
onset (Gorbsky et al., 1998; Waters et al., 1998; Canman et
al., 2000). Therefore, as a third test of the functional activ-
Figure 1. Fluorescent and phase-contrast images of living mitotic PtK1 cells injected with Alexa 488-XMad2. Fluorescent XMad2 is dif-
fusely distributed in the cytoplasm and accumulates in the interphase nucleus. It localizes to unattached kinetochores in prophase (A)
and early prometaphase (B, large arrowhead) and to the spindle poles in prometaphase (B and C, small arrowheads). Fluorescent
XMad2 depletes from kinetochores upon their attachment to the spindle in prometaphase (B, small arrows) and is undetectable on
aligned chromosomes (C). Fluorescent XMad2 is not present at kinetochores or spindle poles during anaphase and telophase. (D). Bar,
3 mm.The Journal of Cell Biology, Volume 150, 2000 1238
ity of our labeled protein, we injected PtK1 cells with anti-
Mad2 antibody to inactivate endogenous Mad2 protein
(Fig. 3, B and C; Waters et al., 1998; Gorbsky et al., 1998;
Canman et al., 2000), and subsequently injected the cells
3–4 min later with fluorescent XMad2 protein (Fig. 3 C).
Real-time phase-contrast and fluorescence microscopy re-
vealed our fluorescent XMad2 protein prevented prema-
ture anaphase onset in antibody-injected cells and that flu-
orescent XMad2 localized to kinetochores and spindle
poles (Fig. 3 C). Finally, we compared the localization of
our fluorescent XMad2 to that of GFP-hMad2 expressed
in PtK1 cells and found similar localization patterns and
behaviors (see Fig. 4; next paragraph).
GFP-hMad2 Shows Similar Localization Patterns in 
Living PtK1 Cells
As an alternative approach to using our recombinant Al-
exa 488-XMad2 probe, we expressed hMad2 protein fused
to GFP in PtK1 cells and examined the localization pat-
tern and dynamic behavior using real-time fluorescence
and phase microscopy. Similar to our Alexa 488-XMad2
probe, GFP-hMad2 localized to unattached kinetochores
in prophase (Fig. 4 A), and disappeared from kinetochores
upon chromosome attachment to the spindle during late
prometaphase/early metaphase (Fig. 4, B and C). GFP-
hMad2 also localized to the spindle poles and along the
spindle microtubules during prometaphase (Fig. 4, B and
C), but was not evident at the kinetochores, spindle fibers,
or spindle poles in anaphase (Fig. 4 D). Consistent with
the Alexa 488-XMad2 studies, treatment of transfected
mitotic PtK1 cells with 20 mM nocodazole resulted in
GFP-hMad2 localization to the kinetochores but not to
the spindle poles (data not shown). We found cells ex-
pressing low amounts of GFP-hMad2 or GFP alone pro-
gressed normally through mitosis (data not shown), but
that high GFP-hMad2 expression often induced a mitotic
block (data not shown). Overall, this localization pattern is
consistent with previous reported immunofluorescent
studies (Chen et al., 1996, 1998; Li and Benezra, 1996;
Gorbsky et al., 1998; Waters et al., 1998) and with our fluo-
rescent XMad2 probe and, therefore, indicates that GFP-
Figure 2. Time-lapse of fluorescent XMad2 protein in a living mitotic PtK1 cell. Fluorescent XMad2 localizes to kinetochores in
prophase (A) and early prometaphase (B), and to spindle poles in prometaphase (C, arrows). Kinetochores leading chromosome con-
gression to the metaphase plate often retain Mad2 localization (D) and polar localization persists (D, arrows). Fluorescent XMad2 di-
minishes at kinetochores in prometaphase (B and C) and at kinetochores and spindle poles in early metaphase (D). After Mad2 has
been depleted from all kinetochores at late metaphase (E), the cells enter anaphase (F). Time is shown in hours:minutes:seconds. (See
Videos 1 and 2 available online at http://www.jcb.org/cgi/content/full/150/6/1233/DC1). Bar, 3 mm.Howell et al. Mad2 and Kinetochore Dynamics In Vivo 1239
hMad2 and Alexa 488-XMad2 behave similar in living
PtK1 cells.
FRAP Analysis Reveals Mad2 Protein Is a Transient 
Component of Kinetochores
The catalytic model of kinetochore function in the verte-
brate spindle checkpoint proposes that unattached kineto-
chores serve as sites for assembling Mad2–Cdc20 com-
plexes, which sequester Cdc20 and keep it from activating
the APC (Chen et al., 1998; Kallio et al., 1998). To exam-
ine if Mad2 is a transient component of kinetochores, as
predicted by this model, we used FRAP techniques to
measure the turnover rate of fluorescent XMad2 protein
Figure 3. Characterization of purified XMad2 protein and analysis of its ability to inhibit premature anaphase onset in PtK1 cells in-
jected with anti-Mad2 antibody. Unlabeled (A, inset lane 1) and Alexa 488–labeled XMad2 protein (A, inset lane 2) were run on a
12.5% SDS–polyacrylamide gel and purity was visualized by silver stain (A, inset). Sedimentation velocity ultracentrifugation was per-
formed to determine the average molecular mass for the unlabeled XMad2. A graph of the concentration (absorbance units) as a func-
tion of rotor radius (r 5 cm2) is shown in A. The shape of the sedimentation curve corresponds to an average molecular mass of 107.5
kD, as determined by the XLA Origin software (see Materials and Methods). B is a time-lapse sequence of premature anaphase onset
in a PtK1 cell z10 min after injection with anti-Mad2 antibody (black arrow). In C, a PtK1 cell is first injected with anti-Mad2 antibody
(a-Mad2, black arrow), and then injected z4 min later with fluorescent XMad2 (Alexa 488-XMad2). Time-lapse phase and fluorescent
imaging shows that the cell does not enter anaphase prematurely and that the fluorescent XMad2 localizes to unattached kinetochores
(small white arrow) and spindle poles (white arrowheads). Mr, markers are (top to bottom): 116, 66, 45, 31, 21.5, and 14 kD. Time is
shown in minutes:seconds. Bar, 5 mm.The Journal of Cell Biology, Volume 150, 2000 1240
on unattached kinetochores. In brief, prophase and early
prometaphase cells were microinjected with fluorescent
XMad2 and unattached kinetochores were photobleached
with a 25-ms exposure from a focused argon ion laser. The
turnover rate of the fluorescent XMad2 protein at pho-
tobleached kinetochores was assessed from time-lapse im-
ages using quantitative fluorescence measurements.
The fluorescent time-lapse sequence from typical FRAP
experiments and the corresponding graphs of fluorescence
recovery can be seen in Fig. 5. In general, we found fluo-
rescent XMad2 turnover occurred rapidly (t1/2 5 26 s, n 5
14) on prometaphase kinetochores and Mad2 fluorescence
recovered an average of 84% of the initial bleached fluo-
rescence (Fig. 5, A and A9, Table I, and Video 3 [available
at http://www.jcb.org/cgi/content/full/150/6/1233/DC1]).
This recovery percentage varied because of the attach-
ment of some kinetochores to spindle microtubules during
image acquisition. We compared fluorescent XMad2 turn-
over rates of prophase versus prometaphase kinetochores
and found the means to be similar, as determined by a t
test (P , 0.01; Table I). Thus, we combined the measure-
ments and reported an overall mean turnover rate for
prophase and prometaphase kinetochores (t1/2 5 28 s, n 5
19; Table I). Notably, although the means were not signifi-
cantly different, we found there was a slight decrease in
the mean turnover rate and a slight decrease in the mean
percent fluorescence recovery of prophase kinetochores
compared with prometaphase kinetochores (Table I). This
observation could be due to differences in kinetochore
structure, Mad2 complexes/binding affinities, or to the
presence of spindle microtubules in prometaphase cells.
Next, we determined if the loss of spindle microtubules
had any effect on the fluorescent XMad2 turnover rate in
vivo. FRAP analysis was performed on fluorescent
XMad2-labeled kinetochores in nocodazole-treated cells,
and an example from a typical FRAP experiment can be
seen in Fig. 5, B and B9. The turnover rate of fluorescent
XMad2 protein at kinetochores in nocodazole-treated
cells (32 s; n 5 15; Table I) was not significantly different
from the turnover rate observed in untreated cells (P ,
0.01; Table I), indicating a similar exchange rate with the
cytoplasmic pool. Notably, however, we found the mean
turnover rate in nocodazole-treated cells to be more simi-
lar to that observed for prophase kinetochores in un-
treated cells. In addition, the mean percent Mad2 fluores-
cence recovery in nocodazole-treated cells was similar to
the mean percent fluorescence recovery in untreated
prophase cells (z61% for nocodazole versus z59% for
prophase kinetochores; P , 0.01; Table I), but was signifi-
cantly different from that of untreated prometaphase ki-
netochores (z84%; P , 0.01; Table I).
Since fluorescent XMad2 protein also localizes to spin-
dle poles in prometaphase cells, we used FRAP techniques
to test if fluorescent XMad2 is also a transient component
of spindle poles. Using FRAP techniques, we observed a
slightly faster turnover rate of Alexa 488-XMad2 protein
at the spindle poles compared with that seen at the kineto-
chores (Fig. 5 C and Table I). For example, spindle poles
had a mean Mad2 t1/2 of 23 s and an average percent fluo-
rescence recovery of z95% (Fig. 5, C and C9, and Table
I). However, using a t test, we found no significant differ-
ence (P , 0.01) in the mean turnover rates for the spindle
poles versus prophase/prometaphase kinetochores. Inter-
estingly, we observed a higher mean percent recovery at
Figure 4. Fluorescent and phase images of GFP-hMad2 in living PtK1 cells. PtK1 cells were transfected with hGFP-MAD2 and ob-
served for protein localization during mitosis. GFP-hMad2 accumulates in the nucleus and localizes to unattached kinetochores in
prophase (A) and prometaphase (B, large arrowhead). During prometaphase, GFP-hMad2 is evident along some spindle fibers and at
the spindle poles (B and C, small arrowheads). GFP-hMad2 fluorescence disappears from kinetochores as they became attached to the
spindle in prometaphase (B, arrow) and aligned at the metaphase plate (C). GFP-hMad2 is not present at kinetochores, along spindle fi-
bers, or at the spindle poles during anaphase (D) and telophase. Bar, 3 mm.Howell et al. Mad2 and Kinetochore Dynamics In Vivo 1241
spindle poles compared with the kinetochores, and often
the recovery percentage of the poles exceeded the initial
(prebleach) fluorescence intensity measurements.
Since Alexa 488-XMad2 and GFP-hMad2 proteins
showed similar localization patterns in PtK1 cells, we ex-
tended our FRAP analysis of Mad2 turnover to cells trans-
fected with GFP-hMAD2. In general, we found GFP-
hMad2 turnover occurred rapidly (t1/2 5 24 s, n 5 12) on
prometaphase kinetochores and recovered an average of
98% of the initial bleached fluorescence (Table I). FRAP
analysis in nocodazole-treated GFP-hMad2 cells revealed
an average t1/2 of 32 s (n 5 9) with a mean fluorescence re-
covery of 76% (Table I). Preliminary studies also suggest
that GFP-hMad2 is a transient component of spindle poles
with a mean t1/2 of 21 s (n 5 6) and an average fluorescence
recovery of 90% (Table I). The consistency between the
GFP-hMad2 and Alexa 488-XMad2 results suggests both
probes are useful in characterizing Mad2 behavior in living
Figure 5. FRAP analysis of
Mad2 turnover at kineto-
chores and spindle poles in
untreated and nocodazole-
treated mitotic PtK1 cells.
Cells were fluorescently im-
aged before and after pho-
tobleaching of a single kineto-
chore (A and B) or spindle
pole (C). Cells were either
untreated (A and C) or
treated with nocodazole for
20 min (B). The prephotobleach, postphotobleach, half recovery (two images), and full recovery time points are shown for each experi-
ment. Arrows denote the photobleaching target. The time is shown in minutes:seconds. Also shown are the corresponding FRAP
graphs of Mad2 turnover at bleached kinetochores (A9 and B9) and spindle poles (C9) in untreated (A9 and C9) and nocodazole-treated
(B9) cells. A closed diamond is used to mark the photobleached kinetochores and spindle poles on the graph. Measurements of back-
ground fluorescence within the cytoplasm were also taken and are plotted on each graph (open triangles). Mad2 diffusion in the cyto-
plasm is rapid and the FRAP is too quick to record. Arrows denote time of photobleaching. (See Video 3 available online at http://
www.jcb.org/cgi/content/full/150/6/1233/DC1). Bars, 3 mm. The Journal of Cell Biology, Volume 150, 2000 1242
cells, and that the kinetic parameters listed in Table I re-
flect the dynamics of endogenous Mad2 at the kineto-
chores and spindle poles.
Photobleaching Does Not Destroy Mad2 at 
Kinetochores or Inhibit Kinetochore Function
The above conclusion is valid provided that photobleach-
ing did not disrupt Mad2 binding to the kinetochore. To
test this possibility, we combined fluorescence microscopy
of living cells and immunofluorescence techniques to visu-
alize fluorescent and nonfluorescent Mad2 protein on
photobleached kinetochores. In brief, mitotic cells were
microinjected with Alexa 488-XMad2 protein and then
imaged before (Fig. 6, Prebleach) and after (Fig. 6, Post-
bleach) photobleaching of a single kinetochore. Within
10–15 s after photobleaching, cells were prefixed briefly to
maintain the postbleached state of the kinetochore (Fig. 6,
Alexa 488-XMad2) and further processed for immunoflu-
orescent staining with anti-Mad2 antibodies (Fig. 6, a-Mad2).
As seen in the fixed cell images, a small amount of fluores-
cent XMad2 protein is detectable on photobleached kinet-
ochores (Fig. 6, Alexa 488-XMad2). This is not surprising,
based on the turnover rate of fluorescent Mad2, and likely
represents a partial turnover of fluorescent Mad2 protein
on these kinetochores before the short prefixation period.
In contrast, further immunofluorescence staining of the
Mad2 protein using anti-Mad2 antibodies revealed a simi-
lar amount of Mad2 protein on the photobleached kineto-
chore compared with other unbleached kinetochores (Fig.
6, a-Mad2). This experiment shows that photobleached ki-
netochores retain normal levels of Mad2 protein, and fur-
ther suggests that photobleaching does not significantly al-
ter kinetochore structure or its ability to bind Mad2
protein.
To further assess possible deleterious effects of pho-
tobleaching on kinetochore function, we used fluorescence
and phase-contrast microscopy to follow mitotic progres-
sion of cells in which Alexa 488-XMad2–labeled kinet-
ochores had been previously bleached. We found that
bleached kinetochores showed no abnormal delay in be-
coming attached to spindle microtubules and chromo-
somes always achieved proper alignment at the metaphase
plate (data not shown). Furthermore, we observed normal
transition periods between metaphase and anaphase on-
set, and proper segregation of sister chromatids whose
kinetochores were previously photobleached (data not
shown).
Mad2 Turnover Is ATP-dependent
The FRAP experiments described above demonstrate that
Mad2 is a transient component of unattached kineto-
chores. Waters et al. (1999) have reported that Mad2 bind-
ing to kinetochores in lysed cell preparations requires ki-
netochore phosphorylation. To examine if Mad2 turnover
requires metabolic energy, we performed FRAP analysis
of labeled kinetochores in ATP-reduced mitotic cells. For
these experiments, PtK1 cells were microinjected with Al-
exa 488-XMad2 protein and incubated for 5–7 min in 5
mM sodium azide and 1 mM 2-deoxyglucose (azide/deoxy-
glucose). Previous studies have used similar concentra-
tions of these inhibitors to reduce cellular ATP levels by
70–90% in PtK1 cells after a treatment period of 5–15 min
(DeBrabender et al., 1981; Bershadsky and Gelfand, 1983;
Spurck et al., 1986a,b).
The results from FRAP experiments in azide/deoxyglu-
cose-treated cells are shown in Table I. In general, we
found Mad2 turnover to be significantly slower in azide/
deoxyglucose-treated cells (t1/2 5 102 s; P , 0.01; Table I)
compared with untreated cells (t1/2 5 28 s; Table I). Ki-
netochores in azide/deoxyglucose-treated cells had a
mean percent fluorescence recovery of z53% during the
5–7-min treatment period (Table I); FRAP analysis after
longer treatments was not possible because of a depletion
of Mad2 fluorescence at the kinetochores (see below). In-
terestingly, Mad2 fluorescence (see Fig. 10) and Mad2
turnover (data not shown) recovered to normal levels on
these kinetochores after cells were rinsed free of meta-
bolic inhibitors with saline G for 5–10 min, thus, illustrat-
ing the reversibility of azide/deoxyglucose treatment.
Overall, this study suggests that Mad2 turnover at the un-
attached kinetochores is dependent on ATP.
Temporal Control of Fluorescent Mad2 Depletion on 
Lagging Chromosomes and Anaphase Onset
A previous study by Rieder et al. (1994) showed anaphase
onset initiates in PtK1 cells z23 6 1 min after the last
chromosome begins congression to the spindle equator.
Furthermore, Gorbsky et al. (1998) demonstrated that
Mad2 function is essential for maintaining the spindle
checkpoint in PtK1 cells and that microinjection of cells
with anti-Mad2 antibody causes premature anaphase on-
set within z8 min. To examine the relationship between
the loss of XMad2 at kinetochores and anaphase onset, we
measured the interval between the loss of fluorescent
Mad2 from kinetochores of the last chromosome to reach
the spindle equator and the onset of anaphase. Late
prophase cells were injected with Alexa 488-XMad2 and
imaged using fluorescence and phase-contrast microscopy
(Fig. 2). We found anaphase onset occurred 10.7 6 1.2 min
(n 5 8) after depletion of fluorescent XMad2 on the kinet-
ochores of the last congressing chromosome. Interestingly,
Table I. Summary of Mad2 FRAP Kinetics at Kinetochores and 
Spindle Poles in Living PtK1 Cells
Experimental conditions k* t1/2* Percent R* n
s21 s
Alexa 488-XMad2
Prophase kinetochores 0.020 6 0.013 35 6 23 59 6 12 5
Prometaphase kinetochores 0.027 6 0.010  26 6 10 84 6 23 14
Prophase and 
prometaphase kinetochores 
(summed)
0.025 6 0.013 28 6 15 78 6 24 19
Nocodazole kinetochores 0.022 6 0.009 32 6 13 61 6 17 15
Azide/deoxyglucose
kinetochores
0.007 6 0.003 102 6 41 53 6 19 6
Spindle poles 0.030 6 0.014 23 6 11  95 6 31 16
GFP-hMad2
Prometaphase kinetochores 0.028 6 0.011 24 6 9 98 6 17 12
Nocodazole kinetochores 0.022 6 0.010 32 6 14 76 6 10 9
Spindle poles 0.033 6 0.011 21 6 7 90 6 24 6
*Determined by exponential regression analysis of recovery curves by plotting
 versus time after photobleaching, as described in Materials and
Methods. R, percent fluorescence recovery. Values are reported 6 SD.
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10.7 min is similar to the time observed by Canman et al.
(2000) between anti-Mad2 antibody injection and ana-
phase onset (11 6 2 min, n 5 8) in our PtK1 cells. This sug-
gests a temporal correlation between the loss of Mad2 pro-
tein on the last kinetochore and inactivation of the spindle
checkpoint.
Visualization of Mad2 Dynamics at Kinetochores, 
Spindle Poles, and along Spindle Microtubules In Vivo
We further used our fluorescent Mad2 probes to visualize
Mad2 and kinetochore structural dynamics in living cells
as the kinetochores interacted with spindle microtubules
during prometaphase. Using high resolution fluorescence
and phase microscopy, we observed fluorescent Mad2 ex-
tensions emanating from kinetochores and stretching
along microtubules in prometaphase and early metaphase
cells (Fig. 7). These streaks varied in length, directionality,
and duration, therefore, we have chosen to classify them
into the following two categories: short streaks (,0.5 mm)
that extended unidirectionally from the kinetochore and
longer streaks (0.5–1.0 mm) extending in either one or both
directions from a kinetochore along the spindle axis. The
short unidirectional streaks (Fig. 7 A) often coincided with
the direction of chromosome movement, and likely repre-
sented stretching of the kinetochore as it interacted with
spindle microtubules. The longer streaks typically lasted
longer than the shorter ones (Fig. 7, B and C). Notably,
Mad2 stretching was never observed in prophase cells or
cells treated with nocodazole (data not shown), indicating
that extensions occur via a microtubule-dependent mecha-
nism. Although we did not simultaneously visualize the in-
teraction of individual microtubules with fluorescent Mad2-
labeled kinetochores, we believe these streaks result from
interactions between lateral microtubules and Mad2 com-
plexes at the kinetochore. Streaks were also evident in PtK1
cells expressing GFP-hMad2 protein (data not shown).
In addition to the Mad2 extensions from kinetochores,
fluorescent Mad2 protein was distributed along the spin-
dle fibers between the kinetochore and the spindle pole
(Figs. 8 and 4). This was observed in most cells and was es-
pecially frequent and evident on the spindle fibers be-
tween monooriented chromosomes and the spindle pole.
On occasion, we also visualized the release of fluorescent
Mad2 particles from kinetochores and transport of these
particles towards the spindle poles (Fig. 8). In general, par-
ticles moved progressively in one direction from the kinet-
ochore towards the spindle pole at a mean rate of 2–3 mm/
min (Fig. 8 and Video 4). However, we did occasionally
observe particles switching direction, pausing, or becom-
ing displaced from the spindle microtubules (data not
shown). An example of a particle being released from a ki-
netochore and transported to the spindle pole can be seen
in Video 4 (available at http://www.jcb.org/cgi/content/full/
150/6/1233/DC1).
When fluorescent Mad2 on a kinetochore disappeared,
fluorescent Mad2 at the proximal pole also decreased and
disappeared. This observation was most clearly seen in
late prometaphase/early metaphase cells when only one or
two chromosomes remained unattached and unaligned on
the spindle (Fig. 9). In general, we observed a loss of Mad2
fluorescence on the kinetochores of the last congressing
chromosome, and then a subsequent loss of Mad2 fluo-
rescence at the proximal spindle pole (Fig. 9 and Video
5 [available at http://www.jcb.org/cgi/content/full/150/6/
1233/DC1]). Fig. 9 C also clearly shows the localization of
fluorescent Mad2 along spindle fibers between a labeled
kinetochore and the proximal spindle pole. Notably, Mad2
fluorescence is not detected on other spindle microtu-
bules/kinetochore fibers. These results collectively indi-
cate that some Mad2 is transported to the spindle poles
along spindle fibers. A loss of Mad2 at the kinetochore
leads to a subsequent loss of Mad2 along spindle fibers
and at the poles.
Figure 6. Photobleached kinet-
ochores retain Mad2. PtK1 cells
were injected with Alexa 488-
XMad2 and imaged by fluores-
cence and phase-contrast mi-
croscopy immediately before
(Prebleach) and after (Post-
bleach) photobleaching of a sin-
gle kinetochore (arrows). Cells
were quickly fixed (,15 s after
photobleaching), lysed, and im-
munofluorescently processed for
Mad2 using anti-Mad2 anti-
bodies. Fixed cells show small
amounts of exogenous Alexa
488-XMad2 fluorescence on
photobleached kinetochores
(Alexa 488-XMad2), however,
anti-Mad2 staining revealed high
concentrations of Mad2 protein
on the photobleached kineto-
chore (a-Mad2). Bar, 3 mm.The Journal of Cell Biology, Volume 150, 2000 1244
Evidence for microtubule-dependent transport of Mad2
complexes between kinetochores and the spindle poles
was also obtained in our studies of the role of ATP in
Mad2 localization. PtK1 cells were injected with Alexa
488-XMad2, treated with azide and 2-deoxyglucose for 30
min (a much longer period than the 5–7-min treatment
used in the FRAP studies), and examined for fluorescent
XMad2 localization. Before treatment with the ATP in-
hibitors, we found fluorescent XMad2 localized strongly to
unattached kinetochores (Fig. 10 A) and to a lesser extent
at the fibers and spindle poles in early prometaphase cells.
Interestingly, Mad2 fluorescence became undetectable at
the kinetochores and fibers and became highly concen-
trated at the spindle poles in prometaphase cells after the
30-min incubation with the ATP inhibitors (Fig. 10 B). Af-
ter a 5–10-min washout period of the ATP inhibitors with
saline G, we found that Mad2 fluorescence recovered to
normal levels at the kinetochores and fibers and dimin-
ished at the spindle poles (Fig. 10 C). To test if the fluores-
cent Mad2 seen at the spindle poles is contributed from ki-
netochores versus the cytoplasm, we examined the effect
of inhibitor treatment on metaphase cells since metaphase
cells lack Mad2 at the kinetochores and the spindle poles
(Fig. 2). We injected early metaphase cells with Alexa 488-
Mad2 and imaged the cells before and after treatment with
ATP inhibitors (Fig. 10, D and E). Notably, we found that
fluorescent Mad2 protein remained undetectable at the ki-
netochores and spindle poles in ATP inhibitor–treated
metaphase cells (Fig. 10 E). Identical results were also ob-
served in fixed cell studies (data not shown) and suggest
that Mad2 protein at kinetochores depletes from the ki-
netochores and accumulates at the spindle poles in cells
with reduced ATP levels.
To test if this relocalization pattern from kinetochores
to poles was dependent on spindle microtubules, we in-
jected PtK1 cells with Alexa 488-XMad2, incubated them
in nocodazole/saline G for 20 min, and imaged them for
fluorescent XMad2. We found that fluorescent XMad2 lo-
calized to all the kinetochores, but was not evident at the
spindle poles (Fig. 10 F). Cells were incubated in nocoda-
zole and azide/deoxyglucose for 30 min and further im-
aged for fluorescent XMad2 localization. In contrast to the
control cells, we were surprised to find the ATP inhibitors
had no effect on Mad2 localization; i.e., fluorescent
Figure 7. Fluorescent Mad2 is extended from kinetochores. Fluorescent XMad2 streaks extended from kinetochores in either one (A
and B) or two (C) directions. KT denotes the location of the kinetochore, whereas P denotes the location of the spindle pole. Time is
shown in minutes:seconds. Bar, 1 mm.Howell et al. Mad2 and Kinetochore Dynamics In Vivo 1245
XMad2 was clearly evident on the kinetochores and not at
the spindle poles (Fig. 10 G). Saline washout had no effect
(Fig. 10 H). Therefore, this study indicates Mad2 relocal-
ization from kinetochores to the spindle poles in azide/
deoxyglucose-treated cells occurs through a microtubule-
dependent translocation mechanism.
Discussion
Mad2 Localizes to Kinetochores, Spindle Poles, and 
Spindle Microtubules in Living PtK1 Cells
In this study, we examined the localization and dynamic
behavior of Mad2 in living PtK1 cells using quantitative
fluorescence and phase-contrast microscopy. After micro-
injection of Alexa 488-XMad2 or expression of GFP-
hMad2 in PtK1 cells, we found Mad2 spread diffusely
throughout the cytoplasm but accumulated rapidly in the
nucleus of interphase and prophase cells, as previously de-
scribed using immunofluorescence in Xenopus XTC tissue
culture cells and mammalian HeLa and LLC-PK cells
(Chen et al., 1996; Gorbsky et al., 1998; Li and Benezra,
1996). Fluorescent Mad2 also localized to unattached ki-
netochores in prophase, to the spindle fibers and poles
during prometaphase, and then disappeared from the
kinetochores upon attachment to the spindle during pro-
metaphase and the spindle poles during late prometa-
phase. The localization of Mad2 to kinetochores in
prophase may play a critical role in the spindle checkpoint.
It suggests Mad2 inhibitory complexes form and begin to
accumulate early in mitosis so as to prevent premature ac-
tivation of the APC.
Our quantitative fluorescent XMad2 measurements in-
dicate unattached prometaphase kinetochores contain be-
tween 1,000–2,000 binding sites for Mad2 protein. It is un-
clear which proteins form the Mad2 binding sites at
kinetochores, along spindle fibers, and at the spindle
poles. However, recent studies have shown that Mad1 is
required for localization of Mad2 to kinetochores (Chen et
al., 1998, 1999).
Our study of Mad2 dynamics in real-time revealed a loss
of Mad2 fluorescence on the kinetochores of the last con-
gressing chromosome with a subsequent loss of Mad2 fluo-
rescence at the proximal spindle pole (Fig. 9). In addition,
we also observed transportation of fluorescent Mad2 par-
ticles from the kinetochores to the spindle poles along
spindle fibers, and found that the relocalization of fluores-
cent Mad2 to the spindle poles in azide/deoxyglucose-
treated cells depended on spindle microtubules and the
presence of Mad2 at kinetochores (Fig. 10). Collectively,
Figure 8. Release of fluorescent
Mad2 particles from kineto-
chores. Fluorescent XMad2 par-
ticles were released from the ki-
netochore and transported
towards the spindle pole via
spindle microtubules. Arrows
denote a release of fluorescent
XMad2 particles. KT denotes
the location of the kinetochore,
whereas P denotes the location
of the spindle pole. Time is
shown in minutes:seconds. Bar, 2
mm. (See Video 4 available
online at http://www.jcb.org/cgi/
content/full/150/6/1233/DC1).The Journal of Cell Biology, Volume 150, 2000 1246
this indicates that spindle microtubules are involved in the
translocation of some of the Mad2 binding sites at kineto-
chores to spindle poles.
Mad2 Is a Transient Component of Kinetochores and 
Spindle Poles
To test the transitory nature of Mad2 association at ki-
netochores, as proposed by current models, we used FRAP
techniques to measure the turnover rate of fluorescent
Mad2 protein on unattached and weakly attached kineto-
chores. We found that Mad2 turnover occurred rapidly on
prophase and prometaphase kinetochores and displayed
an average t1/2 of 28 s for fluorescent XMad2; GFP-hMad2
had a similar t1/2 of 24 s. Interestingly, we found no signifi-
cant difference between the turnover rate of fluorescent
Mad2 protein on kinetochores in prophase, prometaphase,
and nocodazole-treated cells, indicating a similar exchange
rate with the cytoplasmic pool. However, we did find that
treating cells with azide and 2-deoxyglucose to reduce
ATP levels resulted in a significant 3.5-fold decrease in the
Mad2 turnover rate at the kinetochore (from z28 s in un-
treated cells to z102 s in azide/deoxyglucose-treated cells)
before it became completely depleted from kinetochores.
In general, this suggests that Mad2 is a transient compo-
nent of unattached and weakly attached kinetochores and
that Mad2 turnover is dependent on metabolic energy.
We found Mad2 had a similar, but slightly higher, turn-
over rate at the poles compared with kinetochores. Be-
cause of these similar FRAP rates, it is possible that Mad2
associated with the spindle microtubules and the spindle
poles may also contribute to producing inhibitory com-
plexes. If this is the case, then the inhibitory signal could
be amplified beyond that produced by the kinetochore
alone. It will be important to address in the future whether
this dynamic turnover of Mad2 at kinetochores and spin-
dle poles is necessary for checkpoint signaling.
Temporal Link between Kinetochore Mad2 Localization 
and Spindle Checkpoint Activity
Since the current model proposes checkpoint inactivation
Figure 9. The loss of fluorescent XMad2 at spindle poles follows the loss of Mad2 localization to kinetochores. We observed the loss of
fluorescent XMad2 at the kinetochore (small arrow) of a congressing chromosome and the subsequent loss of fluorescent XMad2 at the
proximal spindle pole (B–E, large arrow). Interestingly, fluorescent XMad2 was only evident on the spindle pole proximal to the last
monooriented chromosome (D–F). Time is shown in minutes:seconds. (See Video 5 available online at http://www.jcb.org/cgi/content/
full/150/6/1233/DC1). Bar, 3 mm. Howell et al. Mad2 and Kinetochore Dynamics In Vivo 1247
occurs after depletion of Mad2 from all kinetochores, we
used our fluorescent XMad2 probe to measure the time
delay between the loss of Mad2 on the kinetochores of the
last congressing chromosome and the onset of anaphase.
Using time-lapse fluorescence microscopy, we found cells
did not enter anaphase until all kinetochores had been de-
pleted of fluorescent XMad2 during metaphase. Mad2 did
not become completely depleted until the chromosome
aligned at the metaphase plate, a position where all the mi-
crotubule binding sites become occupied (McEwen et al.,
1997; for review see Rieder and Salmon, 1998). Overall,
we found cells entered anaphase z10 min after depletion
of Mad2 on the last congressing chromosome. This finding
correlates strongly with the data we and others have ob-
served for the time delay between anti-Mad2 antibody in-
jection and sister chromatid separation (Gorbsky et al.,
1998; Canman et al., 2000). One interpretation of this 10-
min delay is that the Mad2-Cdc20 inhibitory complex is
very slow to dissociate (Fig. 11 A). However, this 10-min
period is shorter than the 24-min period reported by Clute
and Pines (1999) as the interval between the start of cyclin
B degradation (APC activation) and anaphase onset. It
will be important to examine in the same cell the quantita-
tive relationship between the depletion of Mad2 at kineto-
chores and cyclin B degradation.
Proposed Model for Spindle Checkpoint Inactivation
Based on our observations, we suggest the following
model for how a single kinetochore produces the wait-
anaphase signal. We propose that microtubule attachment
profoundly alters the structure of the kinetochore (see
Figure 10. Mad2 fluores-
cence decreases at kineto-
chores and increases at
spindle poles after ATP de-
pletion in vivo if the spindle
is present. Untreated (A–E)
and nocodazole-treated (F–H)
cells were injected with fluo-
rescent XMad2 and imaged
in saline with or without no-
codazole (A, D, and F). Cells
were incubated in medium
containing 5 mM sodium
azide and 1 mM 2-deoxy-glu-
cose with or without nocoda-
zole for 30 min, and reim-
aged for Mad2 localization
(B, E, and G). Mad2 fluores-
cence concentrates strongly
at the poles and is undetect-
able at kinetochores in
prometaphase cells after 30
min treatment with inhibitors
(B and B9), but remains
in the cytoplasm in the
metaphase cells (E and E9).
After a saline rinse to wash
out the inhibitors, Mad2 flu-
orescence quickly recovers
on kinetochores and dimin-
ishes at spindle poles in
prometaphase cells (C and
C9). In contrast, however,
Mad2 fluorescence remains
at kinetochores and does not
localize to spindle poles in
nocodazole-treated cells af-
ter the 30-min incubation
with the metabolic inhibitors
(G and G9). Mad2 fluores-
cence in nocodazole-treated
cells remains at the kineto-
chores after a brief washout
of inhibitors with saline (H
and H9). Bar, 5 mm.The Journal of Cell Biology, Volume 150, 2000 1248
also Rieder and Salmon, 1998). In the absence of microtu-
bules, the kinetochore outer plate is a curved structure and
is covered with coronal filaments (Fig. 11; Cassimeris et
al., 1990; Thrower et al., 1996). Both of these features fa-
vor microtubule capture into sites in the outer plate. The
filaments, which contain cytoplasmic dynein and CENP-E
(for review see Rieder and Salmon, 1998), can capture mi-
crotubules by interacting with them laterally, whereas the
curvature of the kinetochore plate allows it to make end-
on interactions with microtubules over a wide range of an-
gles. During the early stages of chromosome attachment to
the spindle these features have the advantage that they al-
low kinetochores over a very wide range of orientations to
capture microtubules that emanate from the spindle poles.
But the very features that increase the probability of chro-
mosome capture can also lead to problems in chromosome
alignment, since a wide capture angle could allow one ki-
netochore to bind microtubules from both poles. We
propose that this misalignment does not occur because ki-
netochores respond to microtubule interactions and at-
tachment by losing their coronal filaments and changing
the surface of the kinetochore to a small disk. A loss of the
coronal filaments prevents interactions with the sides of
microtubules and the disk-like kinetochore outer plate can
only interact with microtubule ends over a narrow angular
range, thus, preventing it from attaching to two spindle
poles at the same time. These changes could be mechani-
cally induced by the interactions with microtubules: minus
end–directed motors on the coronal filaments would tear
them out of the kinetochore and move them to the spindle
poles, whereas the parallel orientation of microtubules
from one pole would gradually force all the microtubule
attachment sites to face towards that pole.
The behavior of Mad2 is most simply explained by pro-
posing that coronal filaments and Mad2 binding sites are
assembled at the kinetochore outer plate domain and can
be transported by microtubules to the poles where they
eventually disassemble (Fig. 11). The Mad2 binding sites
convert Mad2 from an inert form to one that can bind to
and inhibit Cdc20 (Fig. 11). Mad2 can leave the kineto-
chore in two ways: (1) by removal of the coronal filaments
from the kinetochore, (2) or by the release of Mad2 from
binding sites on the coronal filaments that remains at-
tached to the kinetochore. The loss of the budding yeast
Bub1 and Bub3 proteins makes cells very sick, whereas the
loss of Mad1 or Mad2 has little effect in cells whose spin-
dles are normal, even though bub and mad mutations ap-
pear to be equally defective in the spindle checkpoint
(Roberts et al., 1994; for review see Hardwick, 1998). This
observation encourages the speculation that Bub1 and
Bub3 are the structural core of the coronal filaments,
which are needed both to promote rapid microtubule cap-
ture and for the function of the spindle checkpoint. Allow-
ing a polymeric filament that has multiple copies of the
checkpoint proteins to generate the active signaling mole-
cules has the advantage that a single unattached kineto-
chore (and secondarily at the spindle poles) can generate
thousands of inhibitory complexes needed to inhibit most
of the APC in the cell. Thus, upon depletion of Mad2
binding sites from the kinetochore of the last congressing
chromosome, inhibitory complex formation ceases at the
kinetochores (and subsequently at the spindle poles), and
Cdc20 acquires the ability to activate the APC.
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